{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:00:57Z","timestamp":1791568857750,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T00:00:00Z","timestamp":1266278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00259-010-1385-5","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T08:48:52Z","timestamp":1266223732000},"page":"1335-1344","source":"Crossref","is-referenced-by-count":179,"title":["Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial"],"prefix":"10.1007","volume":"37","author":[{"given":"D.","family":"Cordier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Forrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bruchertseifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Apostolidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"M\u00fcller-Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"M\u00e4cke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Reubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,16]]},"reference":[{"issue":"2","key":"1385_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, Gikaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95(2):190\u20138.","journal-title":"J Neurosurg"},{"issue":"10","key":"1385_CR2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"3","key":"1385_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1227\/01.neu.0000317304.31579.17","volume":"62","author":"W Stummer","year":"2008","unstructured":"Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62(3):564\u201376. discussion 564\u2013576.","journal-title":"Neurosurgery"},{"issue":"4","key":"1385_CR4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","volume":"62","author":"N Sanai","year":"2008","unstructured":"Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62(4):753\u201364. discussion 264\u2013756.","journal-title":"Neurosurgery"},{"issue":"5","key":"1385_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7(5):392\u2013401.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1385_CR6","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.nec.2004.07.012","volume":"16","author":"R Fahlbusch","year":"2005","unstructured":"Fahlbusch R, Nimsky C. Intraoperative MRI developments. Neurosurg Clin N Am 2005;16(1):xi\u2013xiii.","journal-title":"Neurosurg Clin N Am"},{"key":"1385_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-7091-0558-0_6","volume":"29","author":"C Nimsky","year":"2004","unstructured":"Nimsky C, Ganslandt O, Fahlbusch R. Functional neuronavigation and intraoperative MRI. Adv Tech Stand Neurosurg 2004;29:229\u201363.","journal-title":"Adv Tech Stand Neurosurg"},{"issue":"21","key":"1385_CR8","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1212\/01.wnl.0000262034.26310.a2","volume":"68","author":"G Kaloshi","year":"2007","unstructured":"Kaloshi G, Benouaich-Amiel A, Diakite F, Tallibert S, Lejeune J, Laigle-Donadey F, et al. Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome. Neurology 2007;68(21):1831\u20136.","journal-title":"Neurology"},{"issue":"9490","key":"1385_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","volume":"366","author":"MJ Bent van den","year":"2005","unstructured":"van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005;366(9490):985\u201390.","journal-title":"Lancet"},{"issue":"8","key":"1385_CR10","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1200\/JCO.2002.08.121","volume":"20","author":"F Pignatti","year":"2002","unstructured":"Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20(8):2076\u201384.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1385_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11864-001-0071-z","volume":"2","author":"VW Stieber","year":"2001","unstructured":"Stieber VW. Low-grade gliomas. Curr Treat Options Oncol 2001;2(6):495\u2013506.","journal-title":"Curr Treat Options Oncol"},{"issue":"15","key":"1385_CR12","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2004.10.169","volume":"22","author":"K Hoang-Xuan","year":"2004","unstructured":"Hoang-Xuan K, Capelle L, Kujas M, Tallibert S, Duffau H, Lejeune J, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004;22(15):3133\u20138.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1385_CR13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","volume":"30","author":"FH Hochberg","year":"1980","unstructured":"Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30(9):907\u201311.","journal-title":"Neurology"},{"issue":"6","key":"1385_CR14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ijc.2910610608","volume":"61","author":"IM Hennig","year":"1995","unstructured":"Hennig IM, Laissue JA, Horisberger U, Reubi JC. Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 1995;61(6):786\u201392.","journal-title":"Int J Cancer"},{"issue":"12","key":"1385_CR15","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1158\/1078-0432.CCR-05-2820","volume":"12","author":"S Kneifel","year":"2006","unstructured":"Kneifel S, Cordier D, Good S, Ionescu MC, Ghaffari A, Hofer S, et al. Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p. Clin Cancer Res 2006;12(12):3843\u201350.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1385_CR16","first-page":"1007","volume":"47","author":"M Boyd","year":"2006","unstructured":"Boyd M, Ross SC, Dorrens J, Fullerton NE, Tan KW, Zalutsky MR, et al. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. J Nucl Med 2006;47(6):1007\u201315.","journal-title":"J Nucl Med"},{"issue":"6","key":"1385_CR17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4161\/cbt.6.6.4089","volume":"6","author":"C Raja","year":"2007","unstructured":"Raja C, Graham P, Abbas Rizvi SM, Song E, Goldsmith H, Thompson J, et al. Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma. Cancer Biol Ther 2007;6(6):846\u201352.","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"1385_CR18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4161\/cbt.4.12.2251","volume":"4","author":"BJ Allen","year":"2005","unstructured":"Allen BJ, Raja C, Rizvi S, Tsui W, Graham P, Thompson JF, et al. Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biol Ther 2005;4(12):1318\u201324.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"1385_CR19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V100.4.1233.h81602001233_1233_1239","volume":"100","author":"JG Jurcic","year":"2002","unstructured":"Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR, et al. Targeted alpha particle immunotherapy for myeloid leukemia. Blood 2002;100(4):1233\u20139.","journal-title":"Blood"},{"issue":"19","key":"1385_CR20","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1021\/ac0580114","volume":"77","author":"C Apostolidis","year":"2005","unstructured":"Apostolidis C, Molinet R, Rasmussen G, Morgenstern A. Production of Ac-225 from Th-229 for targeted alpha therapy. Anal Chem 2005;77(19):6288\u201391.","journal-title":"Anal Chem"},{"issue":"3","key":"1385_CR21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.apradiso.2004.06.013","volume":"62","author":"C Apostolidis","year":"2005","unstructured":"Apostolidis C, Molinet R, McGinley J, Abbas K, Mollenbeck J, Morgenstern A. Cyclotron production of Ac-225 for targeted alpha therapy. Appl Radiat Isot 2005;62(3):383\u20137.","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"1385_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00004356-200506000-00006","volume":"28","author":"H Sangha","year":"2005","unstructured":"Sangha H, Lipson D, Foley N, Salter K, Bhogal S, Pohani G, et al. A comparison of the Barthel Index and the Functional Independence Measure as outcome measures in stroke rehabilitation: patterns of disability scale usage in clinical trials. Int J Rehabil Res 2005;28(2):135\u20139.","journal-title":"Int J Rehabil Res"},{"issue":"3","key":"1385_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/07366290701285108","volume":"25","author":"B Zielinska","year":"2007","unstructured":"Zielinska B, Apostolidis C, Bruchertseifer F, Morgenstern A. An improved method for the production of Ac-225\/Bi-213 from Th-229 for targeted alpha therapy. Solv Extr Ion Exch 2007;25(3):339\u201349.","journal-title":"Solv Extr Ion Exch"},{"issue":"S2","key":"1385_CR24","first-page":"S161","volume":"33","author":"FGS Bruchertseifer","year":"2006","unstructured":"Bruchertseifer FGS, Apostolidis C, M\u00e4cke H, Morgenstern A. An improved method for Bi-213 labelling of DOTA-\/DOTAGA-chelated peptides. Eur J Nucl Med Mol Imaging 2006;33(S2):S161.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1385_CR25","first-page":"1025","volume":"5","author":"A Merlo","year":"1999","unstructured":"Merlo A, Hausmann O, Wasner M, Steiner P, Otte A, Jermann E, et al. Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas. Clin Cancer Res 1999;5(5):1025\u201333.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1385_CR26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<810::AID-IJC19>3.0.CO;2-B","volume":"71","author":"A Merlo","year":"1997","unstructured":"Merlo A, Jermann E, Hausmann O, Chiquet-Ehrismann R, Probst A, Landolt H, et al. Biodistribution of 111In-labelled SCN-bz-DTPA-BC-2\u00a0MAb following loco-regional injection into glioblastomas. Int J Cancer 1997;71(5):810\u20136.","journal-title":"Int J Cancer"},{"issue":"4","key":"1385_CR27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-001-0717-x","volume":"29","author":"T Schumacher","year":"2002","unstructured":"Schumacher T, Hofer S, Eichhorn K, Wasner M, Zimmerer S, Freitag P, et al. Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging 2002;29(4):486\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1385_CR28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/RMR.0b013e31819574ad","volume":"19","author":"C Nimsky","year":"2009","unstructured":"Nimsky C, von Keller B, Schlaffer S, Kuhnt D, Weigel D, Ganslandt O, et al. Updating navigation with intraoperative image data. Top Magn Reson Imaging 2009;19(4):197\u2013204.","journal-title":"Top Magn Reson Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1385-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-010-1385-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1385-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:44:40Z","timestamp":1590623080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1385-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,16]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1385-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,16]]}}}